Age: 28
Free Agency: 2025 (SFA)
Accrued Seasons: 5
- Height: 6'5"
- Weight: 310
- College: Ohio State
- Entry: 2018 Draft, Round 5, #168 overall (Seahawks)
- 2024 Salary Cap Charge: $386,022 (0.15% of cap)
- 2024 Cash Payout: $386,022 (0.13% of spending)
- 2024 Cash to Cap Ratio: 1.00
- Contract Value: $386,022 ($386,022 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 80/103 at LT
Current Contract
(Practice, signed 2024)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2024 | 28 | $302,400 | $386,022 | 0.1% | ||||
| Total | $302,400 | $386,022 | ||||||
Contract Notes
Jamarco Jones signed a two year contract with the Titans on March 15, 2022. Contract value is $4.8 million with $3.15 million guaranteed. Jones received a $750,000 signing bonus and has $950,000 in available incentives.
Cash Flows
| Old Money | 2024 | |
|---|---|---|
| Cash Due | $83,622 | $302,400 |
| Running Cash | $386,022 |
Career Earnings: $5,778,005
Career APY: $1,155,601
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Seahawks | Drafted | Expired | 2018 | 4 | $2,705,004 | $676,251 | $245,004 | $2,628,004 | 97.2% | $657,001 |
| Titans | UFA | Terminated | 2022 | 2 | $4,800,000 | $2,400,000 | $3,150,000 | $2,050,001 | 42.7% | $2,050,001 |
| Lions | SFA | Terminated | 2024 | 1 | $1,055,000 | $1,055,000 | $0 | $0 | 0.0% | $0 |
| Lions | Practice | Elevated | 2024 | 1 | $302,400 | $302,400 | $0 | $0 | 0.0% | $0 |
| Lions | Practice | Elevated | 2024 | 1 | $344,211 | $344,211 | $0 | $0 | 0.0% | $0 |
| Lions | Practice | Active | 2024 | 1 | $386,022 | $386,022 | $0 | $0 | 0.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Seahawks | 4 | $2,628,004 | $657,001 | $2,628,004 | 0.0% | $0 | 0.0% |
| Titans | 1 | $3,150,001 | $3,150,001 | $1,851,470 | 0.0% | $1,475,000 | 0.0% |
| Lions | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Per Game Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | Seahawks | $480,000 | $61,251 | $0 | $0 | $424,251 | 0.2% | $608,004 | ||
| 2019 | Seahawks | $495,000 | $61,251 | $0 | $0 | $556,251 | 0.3% | $495,000 | ||
| 2020 | Seahawks | $675,000 | $61,251 | $0 | $0 | $736,251 | 0.4% | $675,000 | ||
| 2021 | Seahawks | $850,000 | $61,251 | $0 | $0 | $911,251 | 0.5% | $850,000 | ||
| 2022 | Titans | $1,300,000 | $375,000 | $300,000 | $1,300,000 | $1,851,470 | 0.9% | $2,050,001 | ||
| 2024 | Lions | $302,400 | $0 | $0 | $0 | $386,022 | 0.1% | $386,022 | ||
| Total | $4,102,400 | $620,004 | $300,000 | $1,300,000 | $4,865,496 | $5,064,027 | ||||
Dead Money History
| Team | Year | Cap Charge | Cash Paid |
|---|---|---|---|
| Titans | 2023 | $1,475,000 | $1,100,000 | Total | $1,475,000 | $1,100,000 |
Statistics
| Year | Games Played | Games Inactive | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2019 | 15 | 0 | 0 | 28.6% | 13.6% |
| 2020 | 9 | 2 | 0 | 10.7% | 6.5% |
| 2021 | 10 | 1 | 1 | 16.4% | 8.4% |
| 2024 | 2 | 0 | 0 | 0.5% | 0.0% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $0 | $0 |
| Injury Adjusted | $0 | $0 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.